Catalyst Wire Dossier Catalyst Wire Dossier

XULANE

NORELGESTROMIN AND ETHINYL ESTRADIOL · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for XULANE, covering 2014-04-16 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: XULANE — Supplemental Application (Mylan Pharmaceuticals Inc.)

See pricing